Top Pharmaceuticals companies in United States by Capital Expenditure
United States
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -92.27 B
|
Sept. 30, 2024 | USD 93.00 | 1.03% |
|
United States |
|
| 2 |
USD -8.21 B
|
Sept. 30, 2024 | USD 744.91 | -6.59% |
|
United States |
|
| 3 |
USD -5.65 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
| 4 |
USD -3.55 B
|
Sept. 30, 2024 | USD 543.74 | 0.48% |
|
United States |
|
| 5 |
USD -3.42 B
|
Sept. 30, 2024 | USD 99.65 | -1.32% |
|
United States |
|
| 6 |
USD -3.04 B
|
Sept. 29, 2024 | USD 26.41 | -1.46% |
|
United States |
|
| 7 |
USD -2.92 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
| 8 |
USD -2.29 B
|
June 30, 2024 | USD 30.03 | 0.13% |
|
United States |
|
| 9 |
USD -2.24 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
| 10 |
USD -2.01 B
|
Sept. 30, 2024 | USD 92.63 | 1.22% |
|
United States |
|
| 11 |
USD -1.43 B
|
Sept. 30, 2024 | USD 285.03 | 0.91% |
|
United States |
|
| 12 |
USD -1.32 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
| 13 |
USD -1.28 B
|
Sept. 27, 2024 | USD 237.62 | -0.94% |
|
United States |
|
| 14 |
USD -1.23 B
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
| 15 |
USD -1.20 B
|
Sept. 30, 2024 | USD 55.74 | 0.69% |
|
United States |
|
| 16 |
USD -974.00 M
|
Sept. 30, 2024 | USD 267.10 | -1.14% |
|
United States |
|
| 17 |
USD -971.00 M
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
| 18 |
USD -888.00 M
|
Sept. 30, 2024 | USD 175.55 | -0.67% |
|
United States |
|
| 19 |
USD -869.80 M
|
Sept. 30, 2024 | USD 690.87 | -3.63% |
|
United States |
|
| 20 |
USD -809.00 M
|
Sept. 30, 2024 | USD 127.63 | -1.27% |
|
United States |
|
| 21 |
USD -749.00 M
|
Sept. 30, 2024 | USD 34.46 | -1.96% |
|
United States |
|
| 22 |
USD -730.00 M
|
June 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
| 23 |
USD -725.00 M
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
| 24 |
USD -713.00 M
|
Sept. 30, 2024 | USD 63.40 | -0.47% |
|
United States |
|
| 25 |
USD -704.00 M
|
Sept. 30, 2024 | USD 282.63 | -1.65% |
|
United States |
|
| 26 |
USD -637.00 M
|
Sept. 30, 2024 | USD 164.41 | -1.15% |
|
United States |
|
| 27 |
USD -625.61 M
|
Sept. 30, 2024 | USD 44.37 | -2.29% |
|
United States |
|
| 28 |
USD -617.00 M
|
Sept. 30, 2024 | USD 197.96 | -3.26% |
|
United States |
|
| 29 |
USD -591.00 M
|
Sept. 30, 2024 | USD 91.00 | 1.18% |
|
United States |
|
| 30 |
USD -574.00 M
|
Sept. 30, 2024 | USD 87.67 | 0.65% |
|
United States |
|
| 31 |
USD -545.00 M
|
Sept. 30, 2024 | USD 234.50 | 0.17% |
|
United States |
|
| 32 |
USD -543.76 M
|
Sept. 30, 2024 | USD 162.00 | 3.15% |
|
United States |
|
| 33 |
USD -509.00 M
|
Sept. 30, 2024 | USD 124.03 | 2.62% |
|
United States |
|
| 34 |
USD -504.00 M
|
Sept. 30, 2024 | USD 30.62 | 0.39% |
|
United States |
|
| 35 |
USD -487.17 M
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
| 36 |
USD -481.80 M
|
June 30, 2024 | USD 411.66 | -0.41% |
|
United States |
|
| 37 |
USD -423.80 M
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
| 38 |
USD -393.00 M
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
| 39 |
USD -386.50 M
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
| 40 |
USD -386.00 M
|
Sept. 30, 2024 | USD 18.63 | 1.36% |
|
United States |
|
| 41 |
USD -380.80 M
|
Sept. 30, 2024 | USD 328.96 | -3.13% |
|
United States |
|
| 42 |
USD -378.00 M
|
Oct. 31, 2024 | USD 143.43 | 1.04% |
|
United States |
|
| 43 |
USD -374.00 M
|
Sept. 30, 2024 | USD 152.98 | -0.19% |
|
United States |
|
| 44 |
USD -358.70 M
|
Sept. 30, 2024 | USD 143.06 | -4.74% |
|
United States |
|
| 45 |
USD -341.00 M
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
| 46 |
USD -317.37 M
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
| 47 |
USD -307.21 M
|
Sept. 30, 2024 | USD 154.61 | 0.47% |
|
United States |
|
| 48 |
USD -304.20 M
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
| 49 |
USD -286.70 M
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
| 50 |
USD -250.00 M
|
Sept. 30, 2024 | USD 15.81 | 0.96% |
|
United States |
Frequently Asked Questions
-
Which Pharmaceuticals company in United States has the highest Capital Expenditure ?
The Pharmaceuticals company in United States with the highest Capital Expenditure is Coherent, Inc. (NYSE: COHR) at USD -92.27 B.
-
Which Pharmaceuticals company in United States has the lowest Capital Expenditure ?
The Pharmaceuticals company in United States with the lowest Capital Expenditure is Eledon Pharmaceuticals, Inc. (NasdaqCM: ELDN) at USD 0.00.
-
What are the top 10 Pharmaceuticals companies in United States by Capital Expenditure ?
The top 10 Pharmaceuticals companies in United States by Capital Expenditure are Coherent, Inc., Eli Lilly and Company, Johnson & Johnson, UnitedHealth Group Incorporated, Merck & Co., Inc., Pfizer Inc., CVS Health Corporation, Royalty Pharma plc, Abbott Laboratories and Albemarle Corporation.
-
What are the bottom 10 Pharmaceuticals companies in United States by Capital Expenditure ?
The bottom 10 Pharmaceuticals companies in United States by Capital Expenditure are Eledon Pharmaceuticals, Inc., Akero Therapeutics, Inc., SCWorx Corp., Leap Therapeutics, Inc., VYNE Therapeutics Inc., Curis, Inc., Anixa Biosciences, Inc., vTv Therapeutics Inc., Salarius Pharmaceuticals, Inc. and Verastem, Inc..